Geron Corp. Shares Display Perfect Head-and-Shoulders Pattern
What a site, Geron Corp. (NASDAQ:GERN) shares are displaying a beautiful head-and-shoulders pattern. From $5 a share in May to $9 in July then back down to $5 level today. Stem Cells were all the rage a few months ago, now they've just lost steam.
Geron is the company that made news with its stem cell therapy showing benefits in treating spine injuries in rodents' cervical region.
Geron's experimental therapy, GRNOPC1 had earlier run into safety problems as rodents being treated for spinal cord injury in the thoracic region developed a kind of tumor in the animal studies, which prompted the U.S. health regulator to put an early-stage trial on hold.
Data from the current animal study could be used to release the clinical hold and testing the therapy in patients with spinal injuries in the cervical region, the Food and Drug Administration had said in October.
Last month, the stem cell research company said GRNOPC1, reduced tissue damage and improved recovery of nerve function in the proof-of-concept study.
Seven days after injury, rodents treated with GRNOPC1 did not have a cavity in the spinal cord, had more preserved nerve units, and more neurons with their protective covering myelin, Geron said.
Back to the head-and-shoulders pattern, here's a larger view of the chart thanks to finviz.com. So could the stock be a bottom? You make the call.
Disclaimer: No positions in GERN.
Best of the Blogs
Scanning and identifying the best blog entries every hour
- The 20 Habits of Eventual Millionaires | Altucher Confidential
- The U.S. Government Supplied ISIS’ Iconic Pickup Trucks | ZeroHedge
- Is the Lithium Market Set to Explode? | Financial Sense
- China’s Forex Reserves Drop Most on Record: What Does It Mean? | Financial Sense
- The Final Crescendo of Cognitive Dollar Dissonance and the Remonetization of Gold | Financial Sense
- October Macro Update: Employment Wasn't Surprisingly Weak | Financial Sense
- Global Deflation Alert: Hidden EM Debts To China Could Be Immense | ZeroHedge
The most relevant financial news and articles from the Internets
- Outcry in Connecticut brings back canceled Halloween... | Business Insider
- No surprise: Lukashenko wins Belarus presidential race | Business Insider
- 5 things in the new 'Steve Jobs' movie that are completely made up | Business Insider
- China September imports plunge in new sign of weakness | Business Insider
- Rights group says US-backed Kurds displacing Arabs in... | Business Insider
- Pepsi is officially launching its own line of smartphones | Business Insider
- The 105 smartest public colleges in America | Business Insider